NEWS
Our Latest News
ARCHIMED acquires SeqCenter, a fast-growing player in cutting-edge DNA and RNA gene sequencing
SeqCenter is a category leader in Next-Generation Sequencing, which can sequence hundreds of thousands of genes in record-time and at low cost.
Global private equity healthcare specialist ARCHIMED announces the acquisition of Pittsburgh, Pennsylvania-based genetic sequencing provider SeqCenter. SeqCenter’s founding scientists initially worked at the University of Pittsburgh. Frustrated with the pace, cost and difficulty of obtaining sequencing data from existing vendors and academic core laboratories, they developed their own approach to gene sequencing, ultimately leaving academia and founding SeqCenter in 2019.
Provepharm Life Solutions lauréate du prix Galien MedStartUp 2018
November
19,
2019
ARCHIMED delivers three times its investment and a 36 percent internal rate of return with the sale of Italian dental services chain, Primo Group
October
15,
2019
ARCHIMED expands neurodiagnostic business in Europe and the US
September
23,
2019
368